Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2023 Sep 11

PMID 37693221

Authors

Tian Liu

Shangcong Han

Yu Yao

Guiming Zhang

Affiliations

Soon will be listed here.

Abstract

In recent years, the abnormal glucose metabolism of tumor cells has attracted increasing attention. Abnormal glucose metabolism is closely related to the occurrence and development of tumors. Monocarboxylate transporters (MCTs) transport the sugar metabolites lactic acid and pyruvate, which affect glucose metabolism and tumor progression in a variety of ways. Thus, research has recently focused on MCTs and their potential functions in cancer. The MCT superfamily consists of 14 members. MCT1 and MCT4 play a crucial role in the maintenance of intracellular pH in tumor cells by transporting monocarboxylic acids (such as lactate, pyruvate and butyrate). MCT1 and MCT4 are highly expressed in a variety of tumor cells and are involved the proliferation, invasion and migration of tumor cells, which are closely related to the prognosis of cancer. Because of their important functions in tumor cells, MCT1 and MCT4 have become potential targets for cancer treatment. In this review, we focus on the structure, function and regulation of MCT1 and MCT4 and discuss the developed inhibitors of MCT1 and MCT4 to provide more comprehensive information that might aid in the development of strategies targeting MCTs in cancer.

Citing Articles

L- and D-Lactate: unveiling their hidden functions in disease and health.

Li J, Ma P, Liu Z, Xie J Cell Commun Signal. 2025; 23(1):134.

PMID: 40075490 PMC: 11905701. DOI: 10.1186/s12964-025-02132-z.

Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies.

Wang W, Wang H, Wang Q, Yu X, Ouyang L Front Immunol. 2025; 15:1513047.

PMID: 39867891 PMC: 11757118. DOI: 10.3389/fimmu.2024.1513047.

Lactate: a rising star in tumors and inflammation.

Liu H, Pan M, Liu M, Zeng L, Li Y, Huang Z Front Immunol. 2024; 15:1496390.

PMID: 39660139 PMC: 11628389. DOI: 10.3389/fimmu.2024.1496390.

Altered metabolism in cancer: insights into energy pathways and therapeutic targets.

Tufail M, Jiang C, Li N Mol Cancer. 2024; 23(1):203.

PMID: 39294640 PMC: 11409553. DOI: 10.1186/s12943-024-02119-3.

Cancer-associated adipocytes in the ovarian cancer microenvironment.

Cai Q, Yang J, Shen H, Xu W Am J Cancer Res. 2024; 14(7):3259-3279.

PMID: 39113876 PMC: 11301307. DOI: 10.62347/XZRI9189.

References

Fanjul C, Barrenetxe J, Lostao M, Ducroc R . Modulation of intestinal L-glutamate transport by luminal leptin. J Physiol Biochem. 2015; 71(2):311-7. DOI: 10.1007/s13105-015-0414-z. View

Doherty J, Cleveland J . Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013; 123(9):3685-92. PMC: 3754272. DOI: 10.1172/JCI69741. View

De Saedeleer C, Porporato P, Copetti T, Perez-Escuredo J, Payen V, Brisson L . Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration. Oncogene. 2013; 33(31):4060-8. DOI: 10.1038/onc.2013.454. View

Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M . Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109(9):3812-9. DOI: 10.1182/blood-2006-07-035972. View

Zhao Y, Li W, Li M, Hu Y, Zhang H, Song G . Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma. Exp Cell Res. 2019; 384(1):111591. DOI: 10.1016/j.yexcr.2019.111591. View

Tateishi H, Tsuji A, Kato K, Sudo H, Sugyo A, Hanakawa T . Synthesis and evaluation of C-labeled coumarin analog as an imaging probe for detecting monocarboxylate transporters expression. Bioorg Med Chem Lett. 2017; 27(21):4893-4897. DOI: 10.1016/j.bmcl.2017.09.033. View

Hanson J, Gille A, Zwykiel S, Lukasova M, Clausen B, Ahmed K . Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. J Clin Invest. 2010; 120(8):2910-9. PMC: 2912194. DOI: 10.1172/JCI42273. View

Rojas Ayala F, Rocha R, Carvalho K, Carvalho A, da Cunha I, Lourenco S . GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules. 2010; 15(4):2374-87. PMC: 6257354. DOI: 10.3390/molecules15042374. View

Baluapuri A, Wolf E, Eilers M . Target gene-independent functions of MYC oncoproteins. Nat Rev Mol Cell Biol. 2020; 21(5):255-267. PMC: 7611238. DOI: 10.1038/s41580-020-0215-2. View

10.

Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q . Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis. 2012; 33(8):1598-607. PMC: 6276922. DOI: 10.1093/carcin/bgs196. View

11.

Lee Y, Shin K, Park S, Park K, Park S, Heo K . G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion. Oncotarget. 2016; 7(43):70898-70911. PMC: 5342597. DOI: 10.18632/oncotarget.12286. View

12.

Afonso J, Santos L, Miranda-Goncalves V, Morais A, Amaro T, Longatto-Filho A . CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance. Mol Carcinog. 2014; 54(11):1451-66. DOI: 10.1002/mc.22222. View

13.

Ge H, Weiszmann J, Reagan J, Gupte J, Baribault H, Gyuris T . Elucidation of signaling and functional activities of an orphan GPCR, GPR81. J Lipid Res. 2008; 49(4):797-803. DOI: 10.1194/jlr.M700513-JLR200. View

14.

Hosoya K, Kondo T, Tomi M, Takanaga H, Ohtsuki S, Terasaki T . MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina. Pharm Res. 2002; 18(12):1669-76. DOI: 10.1023/a:1013310210710. View

15.

Zhao Z, Wu M, Zou C, Tang Q, Lu J, Liu D . Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway. Cancer Lett. 2013; 342(1):150-8. DOI: 10.1016/j.canlet.2013.08.042. View

16.

Sun X, Wang M, Wang M, Yao L, Li X, Dong H . Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential. Front Cell Dev Biol. 2020; 8:651. PMC: 7379837. DOI: 10.3389/fcell.2020.00651. View

17.

Fei F, Guo X, Chen Y, Liu X, Tu J, Xing J . Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer. J Cancer Res Clin Oncol. 2014; 141(6):1095-102. DOI: 10.1007/s00432-014-1877-y. View

18.

Sasaki S, Kobayashi M, Futagi Y, Ogura J, Yamaguchi H, Iseki K . Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity. PLoS One. 2015; 10(4):e0122738. PMC: 4412719. DOI: 10.1371/journal.pone.0122738. View

19.

Muramatsu T, Miyauchi T . Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol. 2003; 18(3):981-7. DOI: 10.14670/HH-18.981. View

20.

Wilson M, Meredith D, Manning Fox J, Manoharan C, Davies A, Halestrap A . Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005; 280(29):27213-21. DOI: 10.1074/jbc.M411950200. View